Búsqueda | BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas

1.

Mitoxantrone, fluorouracil, and high-dose leucovorin: an effective, well-tolerated regimen for metastatic breast cancer.

Hainsworth, J D; Andrews, M B; Johnson, D H; Greco, F A.

J Clin Oncol ; 9(10): 1731-5, 1991 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-1919624

2.

Paclitaxel with mitoxantrone, fluorouracil, and high-dose leucovorin in the treatment of metastatic breast cancer: a phase II trial.

Hainsworth, J D; Jones, S E; Mennel, R G; Blum, J L; Greco, F A.

J Clin Oncol ; 14(5): 1611-6, 1996 May.

Artículo en Inglés | MEDLINE | ID: mdl-8622079

3.

Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer.

Hainsworth, J D; Burris, H A; Erland, J B; Thomas, M; Greco, F A.

J Clin Oncol ; 16(6): 2164-8, 1998 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-9626217

4.

Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: a Minnie Pearl Cancer Research Network phase II trial.

Hainsworth, J D; Burris, H A; Yardley, D A; Bradof, J E; Grimaldi, M; Kalman, L A; Sullivan, T; Baker, M; Erland, J B; Greco, F A.

J Clin Oncol ; 19(15): 3500-5, 2001 Aug 01.

Artículo en Inglés | MEDLINE | ID: mdl-11481356

5.

Effective therapy for poor-prognosis non-Hodgkin's lymphoma with 8 weeks of high-dose-intensity combination chemotherapy.

Waits, T M; Greco, F A; Greer, J P; Johnson, D H; Wolff, S N; Stein, R S; McMaster, M L; Hainsworth, J D.

J Clin Oncol ; 11(5): 943-9, 1993 May.

Artículo en Inglés | MEDLINE | ID: mdl-7683712

6.

One-hour paclitaxel plus carboplatin in the treatment of advanced non-small cell lung cancer: results of a multicentre, phase II trial.

Hainsworth, J D; Urba, W J; Hon, J K; Thompson, K A; Stagg, M P; Hopkins, L G; Thomas, M; Greco, F A.

Eur J Cancer ; 34(5): 654-8, 1998 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-9713269

7.

Paclitaxel via 1-hour infusion: rationale and pharmacology.

Greco, F A; Hainsworth, J D.

Semin Oncol ; 23(6 Suppl 15): 19-20, 1996 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-8996592

8.

Paclitaxel, carboplatin, and oral etoposide in the treatment of small cell lung cancer.

Greco, F A; Hainsworth, J D.

Semin Oncol ; 23(6 Suppl 16): 7-10, 1996 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-9007113

9.

Paclitaxel via 1-hour infusion: clinical experience.

Greco, F A; Hainsworth, J D.

Semin Oncol ; 23(6 Suppl 16): 91-3, 1996 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-9007131

10.

One-hour paclitaxel in the treatment of non-small cell lung cancer.

Hainsworth, J D; Greco, F A.

Semin Oncol ; 23(6 Suppl 16): 98-101, 1996 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-9007133

11.

Docetaxel (Taxotere) in combination with radiation therapy and the potential of weekly administration in elderly and/or poor performance status patients with advanced non-small cell lung cancer.

Hainsworth, J D; Vokes, E E.

Semin Oncol ; 28(1 Suppl 2): 22-7, 2001 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-11284621

12.

Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.

Hainsworth, J D; Greco, F A.

Semin Oncol ; 22(6 Suppl 15): 45-9, 1995 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-8643970

13.

Paclitaxel with mitoxantrone with or without 5-fluorouracil and high-dose leucovorin in the treatment of metastatic breast cancer.

Greco, F A; Hainsworth, J D.

Semin Oncol ; 24(5 Suppl 17): S17-61-S17-64, 1997 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-9374096

14.

The current role and future prospects of paclitaxel in the treatment of small cell lung cancer.

Hainsworth, J D; Greco, F A.

Semin Oncol ; 26(1 Suppl 2): 60-6, 1999 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-10190785

15.

The evolving role of paclitaxel for patients with carcinoma of unknown primary site.

Greco, F A; Hainsworth, J D.

Semin Oncol ; 26(1 Suppl 2): 129-33, 1999 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-10190795

16.

Weekly docetaxel as a single agent and in combination with gemcitabine in elderly and poor performance status patients with advanced non--small cell lung cancer.

Hainsworth, J D; Burris, H A; Greco, F A.

Semin Oncol ; 28(3 Suppl 9): 21-5, 2001 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-11441411

17.

Weekly administration of docetaxel (Taxotere): summary of clinical data.

Hainsworth, J D; Burris, H A; Greco, F A.

Semin Oncol ; 26(3 Suppl 10): 19-24, 1999 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-10437747

18.

Extended-schedule oral etoposide in selected neoplasms and overview of administration and scheduling issues.

Hainsworth, J D.

Drugs ; 58 Suppl 3: 51-6, 1999.

Artículo en Inglés | MEDLINE | ID: mdl-10711842

19.

Paclitaxel for limited-stage small-cell lung cancer.

Greco, F A; Hainsworth, J D.

J Clin Oncol ; 18(19): 3453-4, 2000 Oct 01.

Artículo en Inglés | MEDLINE | ID: mdl-11013291

20.

The use of mitoxantrone, 5-fluorouracil and high-dose leucovorin in the treatment of advanced breast cancer.

Hainsworth, J D.

Ann Oncol ; 4 Suppl 2: 37-40, 1993.

Artículo en Inglés | MEDLINE | ID: mdl-7688982

BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas - MTCI

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Mitoxantrone, fluorouracil, and high-dose leucovorin: an effective, well-tolerated regimen for metastatic breast cancer.

Paclitaxel with mitoxantrone, fluorouracil, and high-dose leucovorin in the treatment of metastatic breast cancer: a phase II trial.

Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer.

Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: a Minnie Pearl Cancer Research Network phase II trial.

Effective therapy for poor-prognosis non-Hodgkin's lymphoma with 8 weeks of high-dose-intensity combination chemotherapy.

One-hour paclitaxel plus carboplatin in the treatment of advanced non-small cell lung cancer: results of a multicentre, phase II trial.

Paclitaxel via 1-hour infusion: rationale and pharmacology.

Paclitaxel, carboplatin, and oral etoposide in the treatment of small cell lung cancer.

Paclitaxel via 1-hour infusion: clinical experience.

One-hour paclitaxel in the treatment of non-small cell lung cancer.

Docetaxel (Taxotere) in combination with radiation therapy and the potential of weekly administration in elderly and/or poor performance status patients with advanced non-small cell lung cancer.

Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.

Paclitaxel with mitoxantrone with or without 5-fluorouracil and high-dose leucovorin in the treatment of metastatic breast cancer.

The current role and future prospects of paclitaxel in the treatment of small cell lung cancer.

The evolving role of paclitaxel for patients with carcinoma of unknown primary site.

Weekly docetaxel as a single agent and in combination with gemcitabine in elderly and poor performance status patients with advanced non--small cell lung cancer.

Weekly administration of docetaxel (Taxotere): summary of clinical data.

Extended-schedule oral etoposide in selected neoplasms and overview of administration and scheduling issues.

Paclitaxel for limited-stage small-cell lung cancer.

The use of mitoxantrone, 5-fluorouracil and high-dose leucovorin in the treatment of advanced breast cancer.